Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$139.9M
+19.8% from 2023
Prescriptions
12K
$11,788.10 per claim
Patients
1,904
665 prescribers
Total spending, 2024
$140.1M
$73,481.13 per patient
Medicare prescription drug plans paid $139.9M for Keytruda in 2024, for 11,872 prescriptions and refills to 1,904 patients (up 19.8% from 2023). The average cost per claim was $11,788.10.
California had the highest Medicare cost for Keytruda in 2024: $26.8M for 2,335 claims, followed by New York ($23.9M).
Mihran Shirinian, hematology-oncology in Glendale, CA, had the highest Medicare cost for Keytruda in 2024: 199 claims costing $2.1M.
Keytruda is made by Merck & Co., Inc. (MRK), listed in the Medicare spending data as Merck Sharp & D.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mihran Shirinian Glendale, CA | Hematology-Oncology | 199 | 27 | $2.1M |
| Balagopalan Nair Little Rock, AR | Hematology-Oncology | 168 | 27 | $2.0M |
| Swetha S Yadav |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 562 | 7,913 | 1,334 | $91.1M |
| 2023 | 559 | 9,664 | 1,521 | $116.8M |
| 2024 | 665 | 11,872 | 1,904 | $139.9M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 166 |
| 19 |
| $2.0M |
| Youram Nassir Los Angeles, CA | Hematology | 182 | 21 | $2.0M |
| Songchuan Guo Brooklyn, NY | Hematology-Oncology | 178 | 28 | $1.9M |
| Syed S Rafique Greenwood, MS | Hematology-Oncology | 162 | 17 | $1.8M |
| Rohit Kapoor Live Oak, TX | Hematology-Oncology | 141 | 17 | $1.7M |
| Elizabeth J Delgiacco Christiansted, VI | Medical Oncology | 111 | Under 11 | $1.4M |
| Antoine E Chahine Canfield, OH | Medical Oncology | 118 | 14 | $1.3M |
| Maria A Scouros Houston, TX | Hematology-Oncology | 126 | 15 | $1.3M |
| Jen Chin Wang Long Beach, NY | Internal Medicine | 94 | 13 | $1.2M |
| Said Saleh Belleville, NJ | Hematology-Oncology | 96 | Under 11 | $1.1M |
| Eugenio G Galindo McAllen, TX | Hematology-Oncology | 97 | 11 | $1.1M |
| Samuel D Bailey Hazard, KY | Hematology-Oncology | 98 | 12 | $1.1M |
| Zili He X Flushing, NY | Hematology-Oncology | 95 | 18 | $1.0M |
| Amir A Rasheed Baytown, TX | Hematology-Oncology | 90 | Under 11 | $999K |
| Cecilia Choi Makawao, HI | Medical Oncology | 78 | 14 | $997K |
| Yasir Alhassani Temple Terrace, FL | Hematology-Oncology | 83 | 13 | $970K |
| Ashvini Sengar Gadsden, AL | Hematology-Oncology | 74 | Under 11 | $961K |
| Raymond Elsoueidi Hazard, KY | Hematology-Oncology | 79 | 12 | $950K |
| David J Tamura Honolulu, HI | Hematology-Oncology | 70 | Under 11 | $907K |
| Vinicio Hernandez Orlando, FL | Medical Oncology | 80 | 12 | $892K |
| Ilmana Fulger Bronx, NY | Hematology-Oncology | 75 | Under 11 | $881K |
| Jose A Fernandez Chavez South Miami, FL | Hematology-Oncology | 74 | 11 | $876K |
| Ann M Wierman Las Vegas, NV | Hematology-Oncology | 72 | 16 | $862K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Merck Sharp & D MRK | 11,882 | $140.1M |